Bookmark

Add to MyYahoo RSS

Medicines Company The News

News on Medicines Company The (Ticker: MDCO) continually updated from thousands of sources around the net.

Friday Apr 11 | Sys-Con Media

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement...

Today, Analysts Review released its analysts' notes regarding Actavis plc , The Medicines Company , Hospira, Inc. , Horizon Pharma, Inc. , and Galectin Therapeutics Inc. .

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Television, Hispanic Broadcasting

Thu Apr 10, 2014

BioSpace

The Medicines Company To Announce First Quarter 2014 Financial...

The Medicines Company has scheduled its quarterly conference call for Wednesday, April 23 at 8:30 a.m. Eastern Time to discuss first quarter 2014 financial results, operational developments, and outlook for 2014.

Comment?

Related Topix: Biotech, Healthcare Industry, The Medicines Company

Fri Apr 04, 2014

Insider Monkey

Point State Capital Boosts its Stake in The Medicines Company (MDCO) to 7%

MDCO ) . The updated position amounts to almost 4.70 million shares, which represent a 7.30% passive stake in the company's common stock.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, The Medicines Company

Thu Apr 03, 2014

Sys-Con Media

The Zacks Analyst Blog Highlights: Gilead, MannKind, Cubist, Regeneron and Medicines Co

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, MannKind, Cubist Pharmaceuticals, Gilead Sciences, Regeneron Pharmaceuticals

Market Wire

FDA Accepts the Filing of The Medicines Company's US Biologic License ...

The FDA action date for Fibrocaps is January 31, 2015. In August 2013, The Medicines Company announced that the Phase III trial, FINISH-3, which studied a total of 719 patients across 54 sites in the U.S. and Western Europe, met all of its primary and secondary hemostasis efficacy endpoints in each of four distinct populations: spinal surgery; ... (more)

Comment?

Related Topix: Biotech, Healthcare Industry, The Medicines Company, Food and Drug Administration

Wed Apr 02, 2014

BayStreet.ca

Five Star Equities Issues New Research Reports on EPAM, ESS, MDCO and ...

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns.

Comment?

Related Topix: EPAM Systems, Consulting, Healthcare, Health Insurance, Health, Real Estate, Essex Property Trust, Biotech, Medicine, Healthcare Industry, McDermott International, Energy, Oil & Gas

Minyanville

Stock Downgrades: The Medicines Company, Imperial Oil, and Essex Property

Call it dumb luck, but the smart money always seems to fall hard for April Fools' Day.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Real Estate, Essex Property Trust, Alaska Air Group, Airlines, Oil & Gas, Alkane Energy, Energy, Travelzoo, Travel/Tourism, pricelinecom, Computers, Advertising

BayStreet.ca

Nokia Chosen by CaixaBank as Preferred Provider of Employee Phones;...

NOK shares closed up 2.86% on Tuesday with nearly 37 million shares traded. The stock was one of the biggest volume advancers on the NYSE.

Comment?

Related Topix: Nokia, Navteq, Wireless, Telecom, Biotech, Medicine, Healthcare Industry

Tue Apr 01, 2014

Sys-Con Media

the Medicines Company Shareholder Alert by Former Louisiana Attorney...

This action is pending in the United States District Court for the District of New Jersey.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration

Benzinga

Mid-Day Market Update: Verint Shares Jump On Upbeat Results; Medicines Co. Falls

Midway through trading Tuesday, the Dow traded up 0.25 percent to 16,498.20 while the NASDAQ surged 1 percent to 4,240.83.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets, Ku6 Media, Hurray! Holding, Rubicon Technology

TheStreet.com

Why The Medicines Co. (MDCO) Hit a One-Year Low Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, The Medicines Company, Mozilla, TheStreet

Benzinga

Stocks Hitting 52-Week Lows

The Medicines Company shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Financial Markets

Mon Mar 31, 2014

AmericanBankingNews.com

The Medicines Company Stock Rating Lowered by TheStreet

The analysts wrote, "Medicines Company has been downgraded by TheStreet Ratings from buy to hold.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Market Wire

Update on Angiomax(R) (Bivalirudin) Patent Litigation

Hospira, Inc. The case involves Hospira's Abbreviated New Drug Applications seeking approval to commercially manufacture, use or sell a generic version of The Medicines Company's Angiomax bivalirudin drug product before the expiration of the patents covering this product.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Hispanic Broadcasting, Television, The Medicines Company

Sun Mar 30, 2014

Freshnews

Analysis of EUROMAX and HORIZONS-AMI Trials of The Medicines...

EUROMAX and HORIZONS-AMI studies were presented and published individually in September 2008 and October 2013, in The Lancet and The New England Journal of Medicine respectively.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, The Medicines Company, Heart Attack, Health, W., Columbia University

Wed Mar 26, 2014

Customer Interaction Solutions

Shareholder Alert: Levi & Korsinsky, LLP Notifies Investors of Class...

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased The Medicines Company securities between February 20, 2013 and February 12, 2014.

Comment?

Related Topix: New Jersey, Biotech, Medicine, Healthcare Industry

Fri Mar 21, 2014

Sys-Con Media

Shareholders Alert: Pomerantz Law Firm Announces the Filing of a...

The class action, filed in United States District Court, District of , and docketed under 2:33-av-00001, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Medicines securities between both dates inclusive .

Comment?

Related Topix: Healthcare Law, Law, Biotech, Medicine, Healthcare Industry, The Medicines Company, Corporate / Securities Law, Plavix, Clopidogrel (generic), Food and Drug Administration

Mon Mar 17, 2014

GlobeNewswire

Shareholder Alert: Levi & Korsinsky, LLP Notifies Investors of Class...

Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased The Medicines Company securities between February 20, 2013 and February 12, 2014.

Comment?

Related Topix: New Jersey, Biotech, Medicine, Healthcare Industry, Food and Drug Administration

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••
•••